Study Of The Metabolic Parameters Of Uterine Muscle Cells

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-13

Study Completion Date

2020-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To date, no transplant has allowed pregnancy from a donor in a state of brain death. One of the main reservations lies in the ischemic properties of the uterine graft between the sampling time and the grafting time.

Investigators propose to carry out a prospective monocentric study at the University Hospitals of Strasbourg in 2018/2019: the objective would be to study physiologically the time of ischemia of the uterine muscle The objective is to carry out a preparatory study on healthy uteri to study the ischemic properties of uterine muscle from living markers: study of mitochondrial respiration and free radical production on uterine muscle samples If the markers are reliable, they would then be used to measure the ischemia of whole uteri collected at the end of the multi-organ retrieval process from donors in a state of brain death and stored in tissue survival media.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor

NCT05726305

Uterine Factor Infertility

RECRUITING NA

Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study

NCT03277430

Mayer Rokitansky Kuster Hauser Syndrome Mullerian Aplasia Uterus; Absence, Congenital +3 more

RECRUITING PHASE3

Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center

NCT02409147

Uterus Transplant

WITHDRAWN NA

Uterus Transplantation From Live Donor

NCT01844362

Primary Uterine Infertility

COMPLETED NA

Uterus Transplantation From Live Donors With Robotic Assisted Surgery - Gothenburg II

NCT02987023

Infertility, Female

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- Adult patient
* Patient benefiting from the routine management of a programmed hysterectomy by vaginal, laparoscopic or laparotomy for benign pathologies (fibroma, adenomyosis, genital prolapse,...) within the CMCO
* Patient consenting to the use of cells from her uterus for incineration for research purposes
* Patient giving her consent for the use of her medical data for the purposes of this research.
* Patient agreeing to participate in the study

Exclusion Criteria

* \- Patient refusing to participate in the study
* Patient under the protection of justice
* Patient under guardianship or curatorship
* Suspicion of gynaecological malignant pathology
* Pregnant or breastfeeding woman
* Impossibility to give the subject informed information (difficulties in understanding the subject...)

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No